Related Experiment Video

Updated: Aug 9, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB

Roman A Eliseev1, Edward M Schwarz, Michael J Zuscik

  • 1Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA. roman_Eliseev@urmc.rochester.edu

Experimental Cell Research
|November 2, 2005
PubMed

Insights

Nuclear factor kappa B (NFkappaB) represses bone morphogenetic protein (BMP) signaling and osteoblast differentiation in osteosarcoma cells. Inhibiting NFkappaB enhances BMP/Smad signaling and osteogenic gene expression, revealing a key regulatory mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Nuclear factor kappa B (NFkappaB) is constitutively active in tumors, promoting proliferation and inhibiting apoptosis.
  • Bone morphogenetic proteins (BMPs) typically inhibit osteoblastic cell proliferation and promote differentiation and apoptosis.
  • NFkappaB and BMP pathways appear to have opposing roles in osteoblastic cell fate regulation.

Purpose of the Study:

  • To investigate the regulatory relationship between NFkappaB and BMP/Smad signaling in osteosarcoma cells.
  • To determine how NFkappaB influences osteoblast differentiation and BMP signaling pathways.

Main Methods:

  • Overexpression of IkappaB (mIkappaB) to inhibit NFkappaB activity in Saos2 osteosarcoma cells.
  • Analysis of osteoblast phenotypic gene expression (alkaline phosphatase, Runx2, osteocalcin).
  • Assessment of BMP-2 signaling, Smad phosphorylation, and Smad7 expression levels.

Main Results:

  • Inhibition of NFkappaB in Saos2 cells induced osteoblast differentiation and increased expression of osteogenic markers.
  • Saos2 cells with inhibited NFkappaB showed enhanced responsiveness to BMP-2 stimulation.
  • NFkappaB inhibition led to increased BMP-2 signaling and Smad phosphorylation, associated with decreased Smad7 expression.

Conclusions:

  • NFkappaB acts as a repressor of BMP/Smad signaling and BMP2-induced differentiation in osteosarcoma Saos2 cells.
  • The inhibitory effect of NFkappaB on BMP signaling is mediated through the regulation of Smad7 expression.
  • Targeting NFkappaB may represent a therapeutic strategy to promote osteoblast differentiation in osteosarcoma.

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells06:13

Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells

Published on: January 16, 2026

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...